Cybin Inc (AMEX: CYBN)’s stock price has decreased by -4.94 compared to its previous closing price of 0.26. However, the company has seen a -4.98% decrease in its stock price over the last five trading sessions. marketwatch.com reported 2024-08-12 that Shares of companies developing treatments based on psilocybin and other psychedelic drugs moved lower on Monday after the U.S. Food and Drug Administration rejected use of MDMA for post-traumatic stress disorder.
Is It Worth Investing in Cybin Inc (AMEX: CYBN) Right Now?
Opinions on the stock are mixed, with 0 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for CYBN is 695.84M, and at present, short sellers hold a 2.79% of that float. On August 16, 2024, the average trading volume of CYBN was 4.66M shares.
CYBN’s Market Performance
The stock of Cybin Inc (CYBN) has seen a -4.98% decrease in the past week, with a -16.16% drop in the past month, and a -28.54% fall in the past quarter. The volatility ratio for the week is 5.51%, and the volatility levels for the past 30 days are at 6.81% for CYBN. The simple moving average for the past 20 days is -8.77% for CYBN’s stock, with a -32.02% simple moving average for the past 200 days.
CYBN Trading at -9.99% from the 50-Day Moving Average
After a stumble in the market that brought CYBN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -65.92% of loss for the given period.
Volatility was left at 6.81%, however, over the last 30 days, the volatility rate increased by 5.51%, as shares sank -15.94% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -15.97% lower at present.
During the last 5 trading sessions, CYBN fell by -4.76%, which changed the moving average for the period of 200-days by -58.42% in comparison to the 20-day moving average, which settled at $0.2733. In addition, Cybin Inc saw -38.65% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for CYBN
The total capital return value is set at -0.33. Equity return is now at value -49.29, with -47.66 for asset returns.
Based on Cybin Inc (CYBN), the company’s capital structure generated 0.0 points at debt to capital in total, while cash flow to debt ratio is standing at -402.95.
Currently, EBITDA for the company is -78.41 million with net debt to EBITDA at 2.0. The liquidity ratio also appears to be rather interesting for investors as it stands at 41.70.
Conclusion
To sum up, Cybin Inc (CYBN) has seen a bad performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
